Main container

Progetto pediatrico multicentrico nazionale per favorire l’approccio genomico in bambini e adolescenti affetti da tumori solidi ad alto rischio “Studio Genom-ACT”

Title
Progetto pediatrico multicentrico nazionale per favorire l’approccio genomico in bambini e adolescenti affetti da tumori solidi ad alto rischio “Studio Genom-ACT”
Code
Genom-ACT
Type
In Vitro
Start Year
2025
Status
In Corso

Principal Investigator

Operational unit that carry out the study

Description

Studio promosso da AOU Città della Salute e della Scienza Torino.

Documents and Videos attachament

You might also be interested in

Clinical Trial
A Phase 2/3, Randomized, Multicenter Study to Evaluate AL102 in Patients with Progressing Desmoid Tumors
Read more
Clinical Trial
Phase study 1/2 to evaluate palbociclib (IBRANCE®) in combination with irinotecan and temozolomide or in combination with topotecan and cyclophosphamide in pediatric patients with recurrent orrefractory solid tumors
Read more
Content updated
02/05/2025 16:06